164 related articles for article (PubMed ID: 12917635)
21. E1A overcomes the apoptosis block in BCR-ABL+ leukemia cells and renders cells susceptible to induction of apoptosis by chemotherapeutic agents.
Stiewe T; Parssanedjad K; Esche H; Opalka B; Pützer BM
Cancer Res; 2000 Jul; 60(14):3957-64. PubMed ID: 10919674
[TBL] [Abstract][Full Text] [Related]
22. The telomerase inhibitor telomestatin induces telomere shortening and cell death in Arabidopsis.
Zhang L; Tamura K; Shin-ya K; Takahashi H
Biochim Biophys Acta; 2006 Jan; 1763(1):39-44. PubMed ID: 16473138
[TBL] [Abstract][Full Text] [Related]
23. Telomere instability in a human tumor cell line expressing NBS1 with mutations at sites phosphorylated by ATM.
Bai Y; Murnane JP
Mol Cancer Res; 2003 Dec; 1(14):1058-69. PubMed ID: 14707289
[TBL] [Abstract][Full Text] [Related]
24. Resistance to senescence induction and telomere shortening by a G-quadruplex ligand inhibitor of telomerase.
Gomez D; Aouali N; Renaud A; Douarre C; Shin-Ya K; Tazi J; Martinez S; Trentesaux C; Morjani H; Riou JF
Cancer Res; 2003 Oct; 63(19):6149-53. PubMed ID: 14559794
[TBL] [Abstract][Full Text] [Related]
25. Imatinib (STI571) induces DNA damage in BCR/ABL-expressing leukemic cells but not in normal lymphocytes.
Czechowska A; Poplawski T; Drzewoski J; Blasiak J
Chem Biol Interact; 2005 Apr; 152(2-3):139-50. PubMed ID: 15840387
[TBL] [Abstract][Full Text] [Related]
26. Pharmacodynamics of the G-quadruplex-stabilizing telomerase inhibitor 3,11-difluoro-6,8,13-trimethyl-8H-quino[4,3,2-kl]acridinium methosulfate (RHPS4) in vitro: activity in human tumor cells correlates with telomere length and can be enhanced, or antagonized, with cytotoxic agents.
Cookson JC; Dai F; Smith V; Heald RA; Laughton CA; Stevens MF; Burger AM
Mol Pharmacol; 2005 Dec; 68(6):1551-8. PubMed ID: 16150933
[TBL] [Abstract][Full Text] [Related]
27. Apoptosis related to telomere instability and cell cycle alterations in human glioma cells treated by new highly selective G-quadruplex ligands.
Pennarun G; Granotier C; Gauthier LR; Gomez D; Hoffschir F; Mandine E; Riou JF; Mergny JL; Mailliet P; Boussin FD
Oncogene; 2005 Apr; 24(18):2917-28. PubMed ID: 15735722
[TBL] [Abstract][Full Text] [Related]
28. Imatinib mesylate (STI571) abrogates the resistance to doxorubicin in human K562 chronic myeloid leukemia cells by inhibition of BCR/ABL kinase-mediated DNA repair.
Majsterek I; Sliwinski T; Poplawski T; Pytel D; Kowalski M; Slupianek A; Skorski T; Blasiak J
Mutat Res; 2006 Jan; 603(1):74-82. PubMed ID: 16388976
[TBL] [Abstract][Full Text] [Related]
29. Telomerase inhibition potentiates the effects of genotoxic agents in breast and colorectal cancer cells in a cell cycle-specific manner.
Tamakawa RA; Fleisig HB; Wong JM
Cancer Res; 2010 Nov; 70(21):8684-94. PubMed ID: 20837664
[TBL] [Abstract][Full Text] [Related]
30. Telomerase inhibition enhances apoptosis in human acute leukemia cells: possibility of antitelomerase therapy.
Nakajima A; Tauchi T; Sashida G; Sumi M; Abe K; Yamamoto K; Ohyashiki JH; Ohyashiki K
Leukemia; 2003 Mar; 17(3):560-7. PubMed ID: 12646945
[TBL] [Abstract][Full Text] [Related]
31. Energetics of the human Tel-22 quadruplex-telomestatin interaction: a molecular dynamics study.
Agrawal S; Ojha RP; Maiti S
J Phys Chem B; 2008 Jun; 112(22):6828-36. PubMed ID: 18461983
[TBL] [Abstract][Full Text] [Related]
32. [ATM and telomere instability].
Wang HM; Xia YF; Wu XY
Yi Chuan Xue Bao; 2004 Feb; 31(2):212-6. PubMed ID: 15473314
[TBL] [Abstract][Full Text] [Related]
33. Binding of G-quadruplex-interactive agents to distinct G-quadruplexes induces different biological effects in MiaPaCa cells.
Liu W; Sun D; Hurley LH
Nucleosides Nucleotides Nucleic Acids; 2005; 24(10-12):1801-15. PubMed ID: 16438049
[TBL] [Abstract][Full Text] [Related]
34. ATM-dependent telomere loss in aging human diploid fibroblasts and DNA damage lead to the post-translational activation of p53 protein involving poly(ADP-ribose) polymerase.
Vaziri H; West MD; Allsopp RC; Davison TS; Wu YS; Arrowsmith CH; Poirier GG; Benchimol S
EMBO J; 1997 Oct; 16(19):6018-33. PubMed ID: 9312059
[TBL] [Abstract][Full Text] [Related]
35. Telomere dysfunction and telomerase reactivation in human leukemia cell lines after telomerase inhibition by the expression of a dominant-negative hTERT mutant.
Delhommeau F; Thierry A; Feneux D; Lauret E; Leclercq E; Courtier MH; Sainteny F; Vainchenker W; Bennaceur-Griscelli A
Oncogene; 2002 Nov; 21(54):8262-71. PubMed ID: 12447689
[TBL] [Abstract][Full Text] [Related]
36. The G-quadruplex ligand telomestatin inhibits POT1 binding to telomeric sequences in vitro and induces GFP-POT1 dissociation from telomeres in human cells.
Gomez D; O'Donohue MF; Wenner T; Douarre C; Macadré J; Koebel P; Giraud-Panis MJ; Kaplan H; Kolkes A; Shin-ya K; Riou JF
Cancer Res; 2006 Jul; 66(14):6908-12. PubMed ID: 16849533
[TBL] [Abstract][Full Text] [Related]
37. PHA-680626 exhibits anti-proliferative and pro-apoptotic activity on Imatinib-resistant chronic myeloid leukemia cell lines and primary CD34+ cells by inhibition of both Bcr-Abl tyrosine kinase and Aurora kinases.
Gontarewicz A; Balabanov S; Keller G; Panse J; Schafhausen P; Bokemeyer C; Fiedler W; Moll J; Brümmendorf TH
Leuk Res; 2008 Dec; 32(12):1857-65. PubMed ID: 18514829
[TBL] [Abstract][Full Text] [Related]
38. Antitumor effects of telomerase inhibitor TMPyP4 in osteosarcoma cell lines.
Fujimori J; Matsuo T; Shimose S; Kubo T; Ishikawa M; Yasunaga Y; Ochi M
J Orthop Res; 2011 Nov; 29(11):1707-11. PubMed ID: 21590716
[TBL] [Abstract][Full Text] [Related]
39. Telomere dysfunction and Atm deficiency compromises organ homeostasis and accelerates ageing.
Wong KK; Maser RS; Bachoo RM; Menon J; Carrasco DR; Gu Y; Alt FW; DePinho RA
Nature; 2003 Feb; 421(6923):643-8. PubMed ID: 12540856
[TBL] [Abstract][Full Text] [Related]
40. Antitumor effects of celecoxib on K562 leukemia cells are mediated by cell-cycle arrest, caspase-3 activation, and downregulation of Cox-2 expression and are synergistic with hydroxyurea or imatinib.
Zhang GS; Liu DS; Dai CW; Li RJ
Am J Hematol; 2006 Apr; 81(4):242-55. PubMed ID: 16550520
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]